Leafreport Announces Findings From Cannabidiol (CBD) Dosage Survey of More Than 1,360 Respondents, Finds Users Aren’t Checking With a Professional

Survey Finds 71% of CBD Users
Self-determine Dosage Without Consulting a Professional

Tel Aviv, Israel – (NewMediaWire) – October 25, 2021 – Leafreport.com (“Leafreport”
or the “Company”), the CBD industry’s peer-reviewed watchdog website, announced
today the results of a cannabidiol (CBD) dosage survey that found nearly three
quarters of CBD users self-determined their dosage and do not consult with a
professional to determine the appropriate dosage.

For the survey, Leafreport
asked survey participants a total of 11 questions regarding their CBD usage and
dosage habits. Among the findings, Leafreport found that 22% of respondents
didn’t check the dose before taking CBD, and more than 42% decided the dosage
themselves, based on trial and error. In addition, only 29% of CBD users
consulted with a professional to determine their dosage.

“After our team reviewed the
findings from the dosage survey, we realized that most users are not seeking
out the opinions of professionals when trying CBD, which can lead them to
negative experiences,” said Lital Shafir, the head of product at Leafreport.
“Our mission at Leafreport has always been to educate consumers on the many
aspects of the CBD industry, and we want to offer educational tools like
extensive reports for those who want to get away from ‘trial and error’ tactics
when taking CBD.”

In addition, Leafreport’s dosage
survey found that while 48% of respondents take the same dosage every time they
consume CBD, 26% don’t check for CBD concentration when shopping for CBD
products.

The survey also found that 57% of
respondents use CBD for pain and 31% use CBD every day, which speaks to the
current demand for CBD products among users.

This survey is one of many completed by Leafreport aimed at
informing consumers about various aspects of the CBD industry. The Company has
previously sent CBD products to the cannabis testing lab Canalysis to see if
they contained the advertised levels of CBD, among other tests. These reports
include recent deep-dives into topicals, edibles, beverages, and more.

To read the full survey findings
from Leafreport, visit: https://www.leafreport.com/education/spotlight-on-cbd-dosage-71-of-cbd-users-self-determine-dosage-w….

Visit Leafreport.com for
additional reports and product information for consumers related to CBD
products and other topics. 

About Leafreport: Leafreport is a
science-based, peer-reviewed website designed to help consumers navigate the
landscape of CBD. The company’s mission is to introduce transparency into the
CBD industry through its patient-focused, educational content and medical
reviews. The company medical review team consists of physicians, chemists,
nutritionists, pharmacists, chemists and naturopaths.

Contacts:

Lital Shafir

Head of product

Leafreport.com

lital.shafir@leafreport.com

Kyle Porter

CMW Media

CMWMedia.com

leafreport@cmwmedia.com

(858) 264-6600